Related Experiment Videos
Evidence for a link between IGF-I and cancer
Paul J Jenkins1, Stephen A Bustin
1Department of Endocrinology, St Bartholomew's Hospital, London EC1A 7BE, UK. P.J.Jenkins@qmul.ac.uk
European Journal of Endocrinology
|September 2, 2004
Summary
Diet and lifestyle factors influence cancer risk by affecting the growth hormone (GH)/IGF-I axis. Understanding this axis offers insights into cancer prevention and therapy.
Area of Science:
- Endocrinology
- Cancer Biology
- Nutritional Science
Background:
- Cancer risk involves genetic and environmental factors.
- Diet, physical activity, and body size may modulate cancer risk via the IGF-I pathway.
- The growth hormone (GH)/IGF-I axis is crucial for development, homeostasis, and cell functions like proliferation and apoptosis.
Purpose of the Study:
- To explore the role of the GH/IGF-I axis in cancer etiology.
- To investigate how dietary and lifestyle factors influence the GH/IGF-I axis in relation to cancer risk.
- To highlight the potential of targeting the GH/IGF-I axis for cancer prevention and therapy.
Main Methods:
- Review of current evidence on the GH/IGF-I axis and cancer.
- Analysis of molecular mechanisms and signaling pathways involved.
- Correlation of serum IGF-I concentrations with lifestyle factors and cancer risk.
Main Results:
- The GH/IGF-I axis plays a significant role in cell proliferation, differentiation, and apoptosis.
- Dysregulation of the GH/IGF-I axis is implicated in cancer development.
- Dietary and lifestyle factors influence cancer risk through modulation of the GH/IGF-I axis.
Conclusions:
- The GH/IGF-I axis is a key player in cancer development and progression.
- Understanding the GH/IGF-I axis provides novel avenues for cancer prevention strategies.
- Targeting the GH/IGF-I axis holds promise for future cancer therapies.